Austin, Texas, United States KdT Ventures is the famous VC, which was founded in 2017. The company was established in North America in United States. The main office of represented VC is situated in the Austin.
The real fund results show that this VC is 7 percentage points less often commits exit comparing to other companies. The common things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018. The fund is constantly included in 2-6 investment rounds annually.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the KdT Ventures, startups are often financed by Refactor Capital, Y Combinator, Founders Fund. The meaningful sponsors for the fund in investment in the same round are Refactor Capital, Y Combinator, Godfrey Capital. In the next rounds fund is usually obtained by Refactor Capital, Founders Fund, Fifty Years.
The current fund was established by Cain McClary.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Solugen, PathAI, Theator. Among the most successful fund investment fields, there are Manufacturing, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
| Fund Name | Location |
| Amer International Group | China, Guangdong, Shenzhen |
| Bowo Ruize Investment Management Consulting | Beijing, Beijing, China |
| Ecotechnologies Fund | - |
| Enspire Capital | Central Region, Singapore, Singapore |
| Five Four Ventures | New York, New York, United States |
| Hongxin Guotai Touzi | Beijing, China, Haidian |
| Hui Capital | - |
| JG Summit Holdings | Manila, Philippines |
| KBI Biopharma | Durham, North Carolina, United States |
| Kick-Start Funds | - |
| Kirin Holdings | Chiyoda, Japan |
| Mediacorp Singapore | Central, Central Region, Singapore |
| Merapar | Netherlands, Noord-Brabant, North Brabant |
| Pratithi Investment Trust | India, Maharashtra, Mumbai |
| The Logia Group | Herzliya, Israel, Tel Aviv |
| University of Birmingham | Birmingham, England, United Kingdom |
| Vector Media | New York, New York, United States |
| Venture Financial Management | Reston, United States, Virginia |
| Venture Garden Group | Lagos, Lagos, Nigeria |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
March Biosciences | 23 Oct 2024 | Houston, Texas, United States | |||
Montara Therapeutics | $8M | 30 Jul 2024 | San Francisco, California, United States | ||
Marigold Health | $11M | 18 Jun 2024 | Boston, Massachusetts, United States | ||
Radar Therapeutics | $13M | 23 May 2024 | Berkeley, California, United States | ||
Elegen | $35M | 14 May 2024 | San Carlos, California, United States | ||
Motif Neurotech | $18M | 24 Jan 2024 | Houston, Texas, United States | ||
Zymochem | $21M | 16 Jan 2024 | California, United States | ||
Aperiam Bio | $9M | 29 Nov 2023 | Austin, Texas, United States | ||
SURGE Therapeutics | $32M | 19 Jul 2023 | Cambridge, Massachusetts, United States |
– African genomics startup 54gene has raised $25m in Series B funding.
– Pan-African venture capital firm Cathay AfricInvest Innovation Fund led this round.
– Lead investor from the company’s Series A funding, Adjuvant Capital, invested once again with participation from other VCs including KdT Ventures, Plexo Capital, Endeavor Catalyst and Ingressive Capital.
– The company has raised a total of $45m since its inception.
– Bayer’s impact investment arm Leaps has co-led a USD 15m Series A investment round in agriculture and biotechnology innovator, Andes.
– Other new investors Builders VC, Germin8, Accelr8 and Wilson Sonsini participated, alongside existing investors KdT Ventures and Endurance.
– Through its novel seed treatment technology, called ‘Microprime’, Andes is reducing the need for synthetic fertilizers.
– The California-based company has developed a process for seamlessly integrating seeds with a unique library of microbes that colonize the seed’s root structure. This kick-starts a process known as biological nitrogen fixation, enabling the crop to draw down nitrogen from the air instead of relying on synthetic nitrogen fertilizers.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
March Biosciences | 23 Oct 2024 | Houston, Texas, United States | |||
Montara Therapeutics | $8M | 30 Jul 2024 | San Francisco, California, United States | ||
Marigold Health | $11M | 18 Jun 2024 | Boston, Massachusetts, United States | ||
Radar Therapeutics | $13M | 23 May 2024 | Berkeley, California, United States | ||
Elegen | $35M | 14 May 2024 | San Carlos, California, United States | ||
Motif Neurotech | $18M | 24 Jan 2024 | Houston, Texas, United States | ||
Zymochem | $21M | 16 Jan 2024 | California, United States | ||
Aperiam Bio | $9M | 29 Nov 2023 | Austin, Texas, United States | ||
SURGE Therapeutics | $32M | 19 Jul 2023 | Cambridge, Massachusetts, United States |
